Cancer Outcomes 2013 - University of Colorado Hospital

12
CANCER OUTCOMES | 2013

description

University of Colorado Hospital cancer outcomes data for 2013.

Transcript of Cancer Outcomes 2013 - University of Colorado Hospital

Page 1: Cancer Outcomes 2013 - University of Colorado Hospital

C a n C e r O u t C O m e s | 2 0 1 3

Page 2: Cancer Outcomes 2013 - University of Colorado Hospital

4-10 // Outcomes Data

12 // Colorado’s Only Federally Designated Cancer Center

4 // Brain & CNS (Malignant Only) 5–Year Survival

4 // Breast Cancer 5–Year Survival

5 // Colon Cancer 5–Year Survival

5 // Corpus Uteri 5 –Year Survival

6 // Liver Cancer 5–Year Survival

6 // Lung Cancer 5 –Year Survival

7 // Lymphoma Cancer 5–Year Survival

7 // Melanoma of the Skin 5–Year Survival

8 // Ovarian Cancer 5–Year Survival

8 // Pancreas Cancer 5 –Year Survival

9 // Prostate Cancer 5–Year Survival

ta bl e Of COn t e n t s

Page 3: Cancer Outcomes 2013 - University of Colorado Hospital

university Of COlOradO HOspital is tHe leading aCademiC mediCal Center in tHe natiOn.

University of Colorado Hospital (UCH) is recognized as the highest-performing academic hospital in the United

States for delivering quality health care by the University HealthSystem Consortium for two years in a row, and is

ranked as the best hospital in the Denver metro area and one of the best in the country by U.S. News & World Report.

UCH is best known as an innovator in patient care and often is one of the first hospitals to bring new medicine to the

patient’s bedside. The hospital’s physicians are affiliated with the University of Colorado School of Medicine, part of

the University of Colorado system. Based at the expansive Anschutz Medical Campus in Aurora, Colo., UCH is where

patient care, research and education converge to establish the future of health care delivery.

3

Page 4: Cancer Outcomes 2013 - University of Colorado Hospital

*n=18

56%

36%

18%

7%

46%

31%

11%

3%

45%

26%

11%

2%

Stage I Stage II Stage III Stage IV

Lung Cancer - 5 Year Survival

UCH State National

22%

13%

0%

3%

20%

10%

4% 2%

20%

10%

3% 2%

Stage I* Stage II Stage III Stage IV

Pancreas Cancer - 5 Year Survival

UCH State National

73%

61% 54%

49% 47%

58%

45% 38% 36% 34%

52%

36% 30%

37%

25%

Year 1 Year 2 Year 3 Year 4 Year 5

Brain & CNS (Malignant Only) - Survival by Year

UCH State National

83% 77% 79% 77%

Lymphoma - 5 Year Survival

UCH State National

b r a i n & C n s ( m a l i g n a n t O n l y ) 5 – y e a r s u r v i v a l

UCH

Colorado

National

K e y

O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6

( a J C C 6 t H e d i t i O n )

93% 94% 95%

45%

84% 89% 92%

36%

83% 91% 91%

38%

Stage I Stage II Stage III Stage IV

Prostate Cancer - 5 Year Survival

UCH State National

93%

69%

58%

11%

90%

68% 60%

10%

91%

66%

54%

13%

Stage I Stage II Stage III Stage IV

Melanoma of the Skin - 5 Year Survival

UCH State National

96% 92%

62%

41%

92% 86%

75%

26%

92% 85%

67%

21%

Stage I Stage II Stage III Stage IV

Breast Cancer - 5 Year Survival

UCH State National

Lung Cancer - 5 Year Survival

b r e a s t C a n C e r 5 – y e a r s u r v i v a l

4

Ou t C Ome s d ata

Page 5: Cancer Outcomes 2013 - University of Colorado Hospital

*n  =  14

*n  =  22

38%

20%

68%

37%

17%

66%

33%

15%

Stage I Stage II* Stage III Stage IV

88%

69%

49%

23%

74% 67% 64%

9%

78% 67%

55%

10%

Stage I Stage II Stage III* Stage IV

Colon Cancer - 5 Year Survival

UCH State National

C O l O n C a n C e r 5 – y e a r s u r v i v a l

*N = 22

*n=  18

*n  =  20

83% 73% 77%

53%

79% 77% 70%

52%

74% 73%

61% 50%

Stage I Stage II Stage III* Stage IV

UCH State National

52% 48%

14% 14%

35%

25%

4% 2%

33%

26%

6% 2%

Stage I Stage II Stage III Stage IV

Liver Cancer - 5 Year Survival

UCH State National

88% 82%

74%

25%

89%

76% 67%

17%

88%

73%

53%

16%

Stage I Stage II Stage III Stage IV*

Corpus Uteri - 5 Year Survival

UCH State National

94% 84% 89%

68%

85%

66%

Ovarian Cancer - 5 Year Survival

UCH State National

C O r p u s u t e r i 5 – y e a r s u r v i v a l

*N = 20

5

Page 6: Cancer Outcomes 2013 - University of Colorado Hospital

*n=18

56%

36%

18%

7%

46%

31%

11%

3%

45%

26%

11%

2%

Stage I Stage II Stage III Stage IV

Lung Cancer - 5 Year Survival

UCH State National

22%

13%

0%

3%

20%

10%

4% 2%

20%

10%

3% 2%

Stage I* Stage II Stage III Stage IV

Pancreas Cancer - 5 Year Survival

UCH State National

73%

61% 54%

49% 47%

58%

45% 38% 36% 34%

52%

36% 30%

37%

25%

Year 1 Year 2 Year 3 Year 4 Year 5

Brain & CNS (Malignant Only) - Survival by Year

UCH State National

83% 77% 79% 77%

Lymphoma - 5 Year Survival

UCH State National

56%

l u n g C a n C e r 5 – y e a r s u r v i v a l

*n=  18

*n  =  20

83% 73% 77%

53%

79% 77% 70%

52%

74% 73%

61% 50%

Stage I Stage II Stage III* Stage IV

UCH State National

52% 48%

14% 14%

35%

25%

4% 2%

33%

26%

6% 2%

Stage I Stage II Stage III Stage IV

Liver Cancer - 5 Year Survival

UCH State National

88% 82%

74%

25%

89%

76% 67%

17%

88%

73%

53%

16%

Stage I Stage II Stage III Stage IV*

Corpus Uteri - 5 Year Survival

UCH State National

94% 84% 89%

68%

85%

66%

Ovarian Cancer - 5 Year Survival

UCH State National

l i v e r C a n C e r 5 – y e a r s u r v i v a l

UCH

Colorado

National

K e y

O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6

( a J C C 6 t H e d i t i O n )

6

OU T C OME S d aTa

Page 7: Cancer Outcomes 2013 - University of Colorado Hospital

93% 94% 95%

45%

84% 89% 92%

36%

83% 91% 91%

38%

Stage I Stage II Stage III Stage IV

Prostate Cancer - 5 Year Survival

UCH State National

93%

69%

58%

11%

90%

68% 60%

10%

91%

66%

54%

13%

Stage I Stage II Stage III Stage IV

Melanoma of the Skin - 5 Year Survival

UCH State National

96% 92%

62%

41%

92% 86%

75%

26%

92% 85%

67%

21%

Stage I Stage II Stage III Stage IV

Breast Cancer - 5 Year Survival

UCH State National

Lung Cancer - 5 Year Survival

m e l a n O m a O f t H e s K i n 5 – y e a r s u r v i v a l

*n=  18

*n  =  20

83% 73% 77%

53%

79% 77% 70%

52%

74% 73%

61% 50%

Stage I Stage II Stage III* Stage IV

UCH State National

52% 48%

14% 14%

35%

25%

4% 2%

33%

26%

6% 2%

Stage I Stage II Stage III Stage IV

Liver Cancer - 5 Year Survival

UCH State National

88% 82%

74%

25%

89%

76% 67%

17%

88%

73%

53%

16%

Stage I Stage II Stage III Stage IV*

Corpus Uteri - 5 Year Survival

UCH State National

94% 84% 89%

68%

85%

66%

Ovarian Cancer - 5 Year Survival

UCH State National

83% 79%

l y m p H O m a 5– y e a r s u r v i v a l

*N = 18

7

Page 8: Cancer Outcomes 2013 - University of Colorado Hospital

*n=18

56%

36%

18%

7%

46%

31%

11%

3%

45%

26%

11%

2%

Stage I Stage II Stage III Stage IV

Lung Cancer - 5 Year Survival

UCH State National

22%

13%

0%

3%

20%

10%

4% 2%

20%

10%

3% 2%

Stage I* Stage II Stage III Stage IV

Pancreas Cancer - 5 Year Survival

UCH State National

73%

61% 54%

49% 47%

58%

45% 38% 36% 34%

52%

36% 30%

37%

25%

Year 1 Year 2 Year 3 Year 4 Year 5

Brain & CNS (Malignant Only) - Survival by Year

UCH State National

83% 77% 79% 77%

Lymphoma - 5 Year Survival

UCH State National

p a n C r e a s C a n C e r 5 – y e a r s u r v i v a l

*N = 18

94% 84%

38%

20%

89%

68%

37%

17%

85%

66%

33%

15%

Stage I Stage II* Stage III Stage IV

Ovarian Cancer - 5 Year Survival

UCH State National

O v a r i a n 5– y e a r s u r v i v a l

*N = 14

UCH

Colorado

National

K e y

O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6

( a J C C 6 t H e d i t i O n )

8

OU T C OME S d aTa

Page 9: Cancer Outcomes 2013 - University of Colorado Hospital

93% 94% 95%

45%

84% 89% 92%

36%

83% 91% 91%

38%

Stage I Stage II Stage III Stage IV

Prostate Cancer - 5 Year Survival

UCH State National

93%

69%

58%

11%

90%

68% 60%

10%

91%

66%

54%

13%

Stage I Stage II Stage III Stage IV

Melanoma of the Skin - 5 Year Survival

UCH State National

96% 92%

62%

41%

92% 86%

75%

26%

92% 85%

67%

21%

Stage I Stage II Stage III Stage IV

Breast Cancer - 5 Year Survival

UCH State National

Lung Cancer - 5 Year Survival

p r O s t a t e C a n C e r 5 – y e a r s u r v i v a l

*N = 16

9

Page 10: Cancer Outcomes 2013 - University of Colorado Hospital

NCI CANCER CENTERS IN THE USA

= NCI Cancer Center

= NCI Comprehensive Cancer Center

= UCH, NCI Comprehensive Cancer Center

10

The University of Colorado Cancer Center is the hub of cancer research in Colorado. We are a consortium of more

than 400 researchers and physicians at three state universities and six institutions, all working toward one goal:

translating science into cancer survivorship.

C O l O r a d O ’ s O n l y f e d e r a l l y d e s i g n a t e d C a n C e r C e n t e r t a C K l e s C a n C e r f r O m a l l a n g l e s

Page 11: Cancer Outcomes 2013 - University of Colorado Hospital

11

Through collaboration and innovation, CU Cancer Center

members discover, develop and deliver breakthroughs that improve

cancer care for people and companion animals. We focus on:

Personalized care that embraces the best clinical practices of

prevention, diagnosis, treatment and survivorship.

• Innovative interdisciplinary research.

• Premier clinical and scientific training.

• Creative partnerships.

Founded in 1988, CU Cancer Center is the only comprehensive

cancer center designated by the National Cancer Institute in

Colorado and the Rocky Mountain region. Our founding director,

Paul A. Bunn, Jr., MD, led the organization until 2009. In 2010, Dan

Theodorescu, MD, PhD, ushered CU Cancer Center into a new era.

CU Cancer Center is headquartered on the Anschutz Medical

Campus in Aurora, Colo., in the University of Colorado School of

Medicine. Affiliated institutions include University of Colorado

Denver, University of Colorado Boulder, Colorado State University

(including its Flint animal cancer center), University of Colorado

Health, Children’s Hospital Colorado, Denver Veterans Affairs

Medical Center, Denver Health, National Jewish Health and

the Kaiser Permanente’s Institute of Health Research. Our

clinical outreach program extends throughout Colorado and

neighboring states.

HigHl igH t s a nd a C C Omp l i s Hme n t sCU Cancer Center is known clinically for its personalized cancer

treatments and robust and diverse clinical research and trials

program and. Our scientific expertise ranges from understanding

how chromosome structure controls cancer cell behavior, to

understanding how the immune system impacts cancer to carrying

out Phase I trials that bring new therapies to market. Other

strengths include:

NCCN member. The CU Cancer Center is a member of the National

Comprehensive Cancer Network, an alliance of 23 of the world’s

leading cancer centers dedicated to improving the quality,

effectiveness and efficiency of care provided to patients with cancer.

Lung cancer care and research. CU Cancer Center is one of the

world’s best lung cancer research and treatment programs.

We are the coordinating center for the Lung Cancer Mutations

Consortium, funded by a $5.3 million American Reinvestment and

Recovery Act Grand Opportunities grant.

Cancer survivorship. We’re one of eight LIVESTRONG Cancer

Survivorship Centers of Excellence and home to the region’s

three full-scale cancer survivorship clinics: The HOPE clinic for

young adult survivors of cancer at Children’s Hospital Colorado,

the TACTIC clinic for adult survivors of childhood cancer at

University of Colorado Hospital, and the THRIVE clinic for

transitioning adult cancer patients back to primary care.

Cancer screening. The Colorado Colorectal Screening Program

is a national model for ensuring uninsured Coloradans who meet

certain financial and risk criteria receive colon cancer screening

and follow-up care at no cost to them.

Molecular tumor testing. CU Cancer Center has developed tests

that find specific gene defects that can be targeted with new drugs.

These tests have positioned CU Cancer Center as a national leader

for clinical trials of “targeted” drugs.

Cancer clinical trials. CU Cancer Center’s Phase I Trials program

is the only program of its kind in the region and nationally

recognized. In addition, with the largest number of human cancer

clinicals in the region, CU Cancer Center provides patients across

the state and region with access to cutting-edge cancer care.

Structural biology. CU Cancer Center’s NMR spectroscopy and

X-ray facilities are among the best in the world and have helped

recruit world-class scientists to use them. The machines, housed

in CU Cancer Center’s Structural Biology shared resource, help

scientists solve structures of cancer molecules to develop drugs

with precise molecular targeting.

Animal cancer treatment. The Colorado State University Flint

Animal Cancer Center is the world leader in research and

treatment of spontaneously occurring cancers in companion

animals, especially dogs. CU Cancer Center’s members at CSU

collaborate with researchers in human cancers, and clinical trials

in dogs have led to new treatments for people.

l e a r n mOr e :www.coloradocancercenter.org

www.uch.edu

coloradocancerblogs.org

facebook.com/coloradocancercenter

Page 12: Cancer Outcomes 2013 - University of Colorado Hospital